A detailed history of Armstrong Advisory Group, Inc transactions in Viatris Inc stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 1,050 shares of VTRS stock, worth $13,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,050
Previous 1,126 6.75%
Holding current value
$13,650
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$10.32 - $12.13 $784 - $921
-76 Reduced 6.75%
1,050 $12,000
Q2 2024

Jul 12, 2024

BUY
$10.05 - $12.02 $301 - $360
30 Added 2.74%
1,126 $11,000
Q4 2023

Jan 17, 2024

SELL
$8.77 - $10.85 $11,927 - $14,756
-1,360 Reduced 55.37%
1,096 $11,000
Q3 2023

Oct 11, 2023

BUY
$9.59 - $11.35 $20,589 - $24,368
2,147 Added 694.82%
2,456 $24,000
Q2 2023

Jul 06, 2023

BUY
$9.02 - $10.29 $1,398 - $1,594
155 Added 100.65%
309 $3,000
Q4 2022

Jan 17, 2023

BUY
$8.72 - $11.56 $1,342 - $1,780
154 New
154 $0

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.